Document Detail


Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
MedLine Citation:
PMID:  19546386     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Information about physicians' adherence to cholesterol management guidelines remains scant. The present survey updates our knowledge of lipid management worldwide. METHODS AND RESULTS: Lipid levels were determined at enrollment in dyslipidemic adult patients on stable lipid-lowering therapy in 9 countries. The primary end point was the success rate, defined as the proportion of patients achieving appropriate low-density lipoprotein cholesterol (LDL-C) goals for their given risk. The mean age of the 9955 evaluable patients was 62+/-12 years; 54% were male. Coronary disease and diabetes mellitus had been diagnosed in 30% and 31%, respectively, and 14% were current smokers. Current treatment consisted of a statin in 75%. The proportion of patients achieving LDL-C goals according to relevant national guidelines ranged from 47% to 84% across countries. In low-, moderate-, and high-risk groups, mean LDL-C was 119, 109, and 91 mg/dL and mean high-density lipoprotein cholesterol was 62, 49, and 50 mg/dL, respectively. The success rate for LDL-C goal achievement was 86% in low-, 74% in moderate-, and 67% in high-risk patients (73% overall). However, among coronary heart disease patients with > or =2 risk factors, only 30% attained the optional LDL-C goal of <70 mg/dL. In the entire cohort, high-density lipoprotein cholesterol was <40 mg/dL in 19%, 40 to 60 mg/dL in 55%, and >60 mg/dL in 26% of patients. CONCLUSIONS: Although there is room for improvement, particularly in very-high-risk patients, these results indicate that lipid-lowering therapy is being applied much more successfully than it was a decade ago.
Authors:
David D Waters; Carlos Brotons; Cheng-Wen Chiang; Jean Ferri?res; JoAnne Foody; J Wouter Jukema; Raul D Santos; Juan Verdejo; Michael Messig; Ruth McPherson; Ki-Bae Seung; Lisa Tarasenko;
Related Documents :
3570636 - The short- and long-term effects of a low-fat, cholesterol-free, hypocaloric diet on se...
8746876 - Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study.
7934756 - Physical activity, diet, and health: independent and interactive effects.
21443486 - Olive oil and haemostasis: platelet function, thrombogenesis and fibrinolysis.
20105136 - Cross-talk between exogenous statins and endogenous high-density lipoprotein in anti-in...
8181996 - Growth efficiency and digestibility of heated protein fed to growing ruminants.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-06-22
Journal Detail:
Title:  Circulation     Volume:  120     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-07     Completed Date:  2009-07-30     Revised Date:  2010-03-17    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  28-34     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiology, San Francisco General Hospital and University of California, San Francisco, CA 94114, USA. dwaters@medsfgh.ucsf.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antilipemic Agents / therapeutic use*
Cholesterol, HDL / blood
Cholesterol, LDL / blood*
Coronary Disease / epidemiology*
Diabetes Mellitus / epidemiology
Female
Guideline Adherence
Health Care Surveys
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / blood,  drug therapy*,  epidemiology*
Male
Middle Aged
Risk Factors
Smoking / epidemiology
World Health
Chemical
Reg. No./Substance:
0/Antilipemic Agents; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors
Comments/Corrections
Comment In:
Circulation. 2010 Mar 9;121(9):e233   [PMID:  20212288 ]
Circulation. 2009 Jul 7;120(1):3-5   [PMID:  19546383 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Visually-Guided Balloon Catheter Ablation of Atrial Fibrillation: Experimental Feasibility and First...
Next Document:  Safety and Efficacy of Recombinant Activated Factor VII: A Randomized Placebo-Controlled Trial in th...